BNP Paribas Financial Markets Grows Position in Azenta, Inc. (NASDAQ:AZTA)

BNP Paribas Financial Markets grew its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 285.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,227 shares of the company's stock after acquiring an additional 23,132 shares during the period. BNP Paribas Financial Markets owned 0.06% of Azenta worth $1,513,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AZTA. Hantz Financial Services Inc. acquired a new stake in Azenta during the second quarter worth about $30,000. Farther Finance Advisors LLC boosted its holdings in shares of Azenta by 20.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock valued at $74,000 after purchasing an additional 256 shares in the last quarter. Benjamin F. Edwards & Company Inc. increased its stake in shares of Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company's stock valued at $84,000 after purchasing an additional 955 shares during the last quarter. Net Worth Advisory Group acquired a new position in shares of Azenta during the 3rd quarter worth $205,000. Finally, Sanctuary Advisors LLC bought a new stake in shares of Azenta during the 2nd quarter worth $222,000. 99.08% of the stock is owned by institutional investors and hedge funds.

Azenta Price Performance

AZTA traded up $1.25 during trading on Monday, hitting $46.84. The company's stock had a trading volume of 478,360 shares, compared to its average volume of 560,586. The stock's fifty day moving average price is $44.72 and its 200-day moving average price is $49.69. Azenta, Inc. has a twelve month low of $38.82 and a twelve month high of $69.16.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, beating analysts' consensus estimates of $0.10 by $0.08. The business had revenue of $170.00 million during the quarter, compared to analyst estimates of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The firm's revenue was down 1.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.13 EPS. On average, equities analysts anticipate that Azenta, Inc. will post 0.41 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Evercore ISI lowered their target price on Azenta from $53.00 to $50.00 and set an "in-line" rating for the company in a research note on Tuesday, October 1st. Needham & Company LLC cut their target price on shares of Azenta from $69.00 to $55.00 and set a "buy" rating on the stock in a research report on Wednesday, November 13th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $63.60.

Insider Buying and Selling at Azenta

In other news, Director William L. Cornog purchased 12,500 shares of the business's stock in a transaction that occurred on Monday, November 18th. The shares were acquired at an average cost of $39.60 per share, for a total transaction of $495,000.00. Following the completion of the acquisition, the director now owns 14,755 shares in the company, valued at $584,298. This trade represents a 554.32 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Herman Cueto sold 1,595 shares of the company's stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of $43.68, for a total value of $69,669.60. Following the completion of the transaction, the chief financial officer now directly owns 24,604 shares of the company's stock, valued at approximately $1,074,702.72. This represents a 6.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 3,018 shares of company stock worth $126,689. 1.77% of the stock is owned by corporate insiders.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.